Related Experiment Video

Updated: Jul 10, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
06:03

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis

Published on: May 9, 2025

Transforming growth factor-beta activation in the lung: focus on fibrosis and reactive oxygen species

Katri Koli1, Marjukka Myllärniemi, Jorma Keski-Oja

  • 1Department of Virology, Haartman Institute, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.

Antioxidants & Redox Signaling
|October 27, 2007
PubMed

Insights

Transforming growth factor-betas (TGF-beta) are crucial for cell function but are kept inactive until released. Reactive oxygen species (ROS) can activate TGF-beta, impacting lung diseases like COPD.

Area of Science:

  • Cellular Biology
  • Pulmonary Medicine
  • Biochemistry

Background:

  • Transforming growth factor-betas (TGF-beta) regulate cellular functions, tissue homeostasis, and disease pathogenesis.
  • TGF-beta is stored in an inactive form within the extracellular matrix, requiring release and activation for biological activity.
  • Reactive oxygen species (ROS) play a dual role, activating TGF-beta and being induced by TGF-beta signaling.

Purpose of the Study:

  • To explore the intricate relationship between TGF-beta, ROS, and lung pathophysiology.
  • To investigate the role of TGF-beta activation in pulmonary fibrosis and chronic obstructive pulmonary disease (COPD).

Main Methods:

  • Review of existing literature on TGF-beta regulation, ROS signaling, and lung diseases.
  • Analysis of the mechanisms by which ROS influence TGF-beta activation.
  • Examination of TGF-beta's role in lung repair, connective tissue turnover, and disease progression.

Main Results:

  • TGF-beta activation, often mediated by ROS, is a key event in pulmonary fibrosis.
  • Cigarette smoking-induced oxidative stress activates TGF-beta in COPD.
  • TGF-beta signaling is implicated in the pathogenesis of emphysema, airway fibrosis, and focal lung fibrosis.

Conclusions:

  • The interplay between TGF-beta and ROS is critical in lung disease development and progression.
  • Targeting TGF-beta activation pathways may offer therapeutic strategies for lung fibrosis and COPD.
  • Understanding ROS-mediated TGF-beta activation is essential for managing oxidative stress-related pulmonary conditions.

More Related Videos

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition06:02

Development of an In Vitro Assay to Evaluate Contractile Function of Mesenchymal Cells that Underwent Epithelial-Mesenchymal Transition

Published on: June 10, 2016

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...